Prestige Consumer Healthcare
PBH
#4454
Rank
NZ$4.30 B
Marketcap
NZ$90.72
Share price
0.06%
Change (1 day)
-14.27%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2026 (TTM): NZ$5.69

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is NZ$5.96. In 2025 the company made an earnings per share (EPS) of NZ$6.96 a decrease over its 2024 EPS that were of NZ$7.86.

EPS history for Prestige Consumer Healthcare from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$5.69-18.33%
2025NZ$6.96-11.4%
2024NZ$7.86-367.08%
2023NZ-$2.94-138.33%
2022NZ$7.6811.7%
2021NZ$6.8713.6%
2020NZ$6.05-651.67%
2019NZ-$1.10-148.78%
2018NZ$2.25-83.29%
2017NZ$13.45437.23%
2016NZ$2.50-34.13%
2015NZ$3.8052.94%
2014NZ$2.49-8.11%
2013NZ$2.71
2011NZ$1.59

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.21 104.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
NZ$12.36 107.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$9.60 61.04%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.30-78.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$4.94-17.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
NZ$8.90 49.39%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
NZ$5.85-1.84%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.26-11.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
NZ-$54.15-1,008.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
NZ$2.23-62.58%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel